© 1995 Oxford University Press
research-article |
Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine
1Laboratory of Pathology, Aichi Cancer Center Research Institute Kanokoden, Chikusa-ku, Nagoya 4-64
2First Department of Pathology, Osaka City University Medical School Asahi-machi, Abeno-ku, Osaka 545
3Aburahi Laboratories, Shionogi Research Laboratories, Shionogi Co. Ltd Koka-cho, Koka-gun, Shiga 520-34, Japan
To elucidate whether common genetic events in human urinary bladder carcinogenesis also occur in rodent models, we investigated the presence of p53, H- and K-ras mutations in 18 urinary bladder carcinomas induced by various concentrations of N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in male NON/Shi mice. Histopathologically, all were invasive, 11 being squamous cell carcinomas (SCCs) and the remaining seven being transitional cell carcinomas (TCCs). Using polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis followed by DNA sequencing, p53, H- and K-ras mutations were observed in 14 (78%; exons 57), two (11%; one each on exons 1 and 2) and one (5.6%; exon 1) animals respectively. The frequencies of mutations in p53 exons 5, 6 and 7 were 7 (39%), 4 (22%), and 9 (50%) respectively, and no mutation was found in exon 8. All mutations involved one base-pair substitution with or without amino acid changes and the types of base-pair substitution were random. No evident association was observed between mutation sites and the histological phenotypes. In conclusion, p53 mutations are frequent in BBN-induced mouse invasive urinary bladder tumors, at similar levels to those observed for human high-grade invasive carcinomas, and this plus their distribution suggests their possible participation in this model of urinary bladder carcinogenesis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Kushida, S. Aiso, K. Morimura, M. Wei, H. Wanibuchi, K. Nagano, and S. Fukushima Absence of {beta}-Catenin Alteration in Hepatic Tumors Induced by p-Nitroanisole in Crj:BDF1 Mice Toxicol Pathol, April 1, 2006; 34(3): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mori, A. Koide, K. Fuwa, H. Wanibuchi, and S. Fukushima Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53(+/-) knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine Mutagenesis, September 1, 2001; 16(5): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamoto, T. Tsukamoto, H. Sakai, N. Shirai, H. Ohgaki, C. Furihata, L. A. Donehower, K. Yoshida, and M. Tatematsu p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis Carcinogenesis, October 1, 2000; 21(10): 1891 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, M. Asamoto, H. Toriyama-Baba, F. Yamamoto, Y. Matsuoka, T. Ochiya, T. Sekiya, M. Terada, H. Akaza, and H. Tsuda Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis Carcinogenesis, July 1, 2000; 21(7): 1391 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Delker, B. L. Yano, and B. B. Gollapudi Evaluation of Cytotoxicity, Cell Proliferation, and Genotoxicity Induced by p-Cresidine in Hetero- and Nullizygous Transgenic p53 Mice Toxicol. Sci., June 1, 2000; 55(2): 361 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamamoto, A. Romanenko, M. Wei, C. Masuda, W. Zaparin, W. Vinnichenko, A. Vozianov, C. C. R. Lee, K. Morimura, H. Wanibuchi, et al. Specific p53 Gene Mutations in Urinary Bladder Epithelium after the Chernobyl Accident Cancer Res., August 1, 1999; 59(15): 3606 - 3609. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Morimura, S. Yamamoto, T. Murai, S. Mori, T.-X. Chen, H. Wanibuchi, and S. Fukushima LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine Carcinogenesis, April 1, 1999; 20(4): 715 - 718. [Abstract] [Full Text] [PDF] |
||||




